ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
CHEMOCENTRYX (NASDAQ: CCXI) Delayed: 13.58 +0.68 (5.27%)
Previous Close $12.90    52 Week High $8.30 
Open $13.03    52 Week Low $1.92 
Day High $13.64    P/E N/A 
Day Low $12.81    EPS $-1.00 
Volume 2,360,016